• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Optimal timing of cefuroixime surgical antimicrobial prophylaxis may decrease surgical site infection risk

byRhianna DavisandAlex Chan
June 18, 2023
in Infectious Disease, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Among 538,967 adult participants who underwent major surgery, administration of prophylactic cefuroxime at 0-30 or 31-60 minutes resulted in a significantly lower risk of surgical site infections, compared to administration at 61-120 minutes. 

Evidence Rating Level: 3 (Average)

Surgical site infections (SSIs) are an important healthcare concern, given that they account for nearly 20% of all healthcare-related infections. Though current WHO guidelines recommend providing antibiotics 120 minutes prior to surgery, there is a scarcity in literature characterizing the optimal time of antibiotic administration. In this cohort study, researchers aimed to assess whether the timing of cefuroxime administration impacted the incidence of surgical site infections. The study included 538,967 adult participants who underwent major surgery between January 2009 and December 2020 in Switzerland, documented by the Swissnoso SSI surveillance system. Participants were divided into three groups based on the timing of cefuroxime prophylaxis prior to the first incision: 0-30 minutes (34.7%), 31-60 minutes (53.1%), and 61-120 minutes (12.2%). 5355 (2.4%) of patients developed an SSI. Compared to the 61-120 minute group, a lower rate of surgical site infections was found with cefuroxime administration at 0-30 minutes (adjusted odds ratio, 0.85; 95% CI, 0.78-0.93; P < .001) and 31-60 minutes (aOR, 0.91; 95% CI, 0.84-0.98; P = .01). Findings indicate that the current guidelines may not reflect best practices, and patients may benefit from antibiotics closer to the time of incision. An important limitation of this study is that the authors did not adjust for confounding variables that likely impact the incidence of infection, such as diabetes, smoking, immunodeficiency, or the type of surgery performed. Although further research in the area is required prior to guideline and practice changes, study findings may indicate that changing antibiotic prophylaxis closer to time of incision may be a simple but effective strategy in decreasing SSIs.

Click to read the study in JAMA Network Open

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

Trastuzumab deruxtecan leads to longer overall survival than ramucirumab plus paclitaxel in HER2-positive gastric cancer

Tags: antibioticsinfectionSurgerysurgical site infection
Previous Post

South Korea observed to have decrease in physical activity during the COVID-19 pandemic

Next Post

2 Minute Medicine Rewind June 19, 2023

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Career Development

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

September 18, 2025
Long-term dual antiplatelet therapy does not increase mortality risk
Hematology

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

September 9, 2025
Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria
Gastroenterology

Trastuzumab deruxtecan leads to longer overall survival than ramucirumab plus paclitaxel in HER2-positive gastric cancer

August 27, 2025
Elective neck dissection may be unnecessary for adenoid cystic carcinoma
Oncology

Pembrolizumab improves survival in locally advanced head and neck cancer

August 26, 2025
Next Post
Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

2 Minute Medicine Rewind June 19, 2023

Female incontinence associated with physical activity

Habitual diet choices may be linked to exercise-related abdominal complaints

Patient Basics: Lung Cancer Overview

Overall Survival Improved with Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial
  • A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults: A Randomized Clinical Trial
  • Multidomain rehabilitation after myocardial infarction improves outcomes in older adults
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.